1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Acinetobacter Infections Treatment Consumption 2016-2026

2.1.2 Acinetobacter Infections Treatment Consumption CAGR by Region

2.2 Acinetobacter Infections Treatment Segment by Type

2.2.1 Sulbactam

2.2.2 Carbapenems

2.2.3 Aminoglycosides

2.2.4 Polymyxins

2.2.5 Tetracyclines

2.2.6 Others

2.3 Acinetobacter Infections Treatment Sales by Type

2.3.1 Global Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)

2.3.2 Global Acinetobacter Infections Treatment Revenue and Market Share by Type (2016-2021)

2.3.3 Global Acinetobacter Infections Treatment Sale Price by Type (2016-2021)

2.4 Acinetobacter Infections Treatment Segment by Application

2.4.1 ETX2514

2.4.2 Nacubactam RG6080

2.4.3 Arenicin

2.4.4 VXD-001

2.4.5 Small Molecule Antibiotic

2.4.6 AR-401 mAB

2.4.7 LCB01-0371 (PO)

2.4.8 GN-4474

2.4.9 Antibacterial Antibody

2.5 Acinetobacter Infections Treatment Sales by Application

2.5.1 Global Acinetobacter Infections Treatment Sale Market Share by Application (2016-2021)

2.5.2 Global Acinetobacter Infections Treatment Revenue and Market Share by Application (2016-2021)

2.5.3 Global Acinetobacter Infections Treatment Sale Price by Application (2016-2021)

3 Global Acinetobacter Infections Treatment by Company

3.1 Global Acinetobacter Infections Treatment Sales Market Share by Company

3.1.1 Global Acinetobacter Infections Treatment Sales by Company (2019-2021)

3.1.2 Global Acinetobacter Infections Treatment Sales Market Share by Company (2019-2021)

3.2 Global Acinetobacter Infections Treatment Revenue Market Share by Company

3.2.1 Global Acinetobacter Infections Treatment Revenue by Company (2019-2021)

3.2.2 Global Acinetobacter Infections Treatment Revenue Market Share by Company (2019-2021)

3.3 Global Acinetobacter Infections Treatment Sale Price by Company

3.4 Global Manufacturers Acinetobacter Infections Treatment Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Acinetobacter Infections Treatment Product Location Distribution

3.4.2 Players Acinetobacter Infections Treatment Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Acinetobacter Infections Treatment by Region

4.1 Global Acinetobacter Infections Treatment by Region

4.1.1 Global Acinetobacter Infections Treatment Sales by Region

4.1.2 Global Acinetobacter Infections Treatment Revenue by Region

4.2 Americas Acinetobacter Infections Treatment Sales Growth

4.3 APAC Acinetobacter Infections Treatment Sales Growth

4.4 Europe Acinetobacter Infections Treatment Sales Growth

4.5 Middle East & Africa Acinetobacter Infections Treatment Sales Growth

5 Americas

5.1 Americas Acinetobacter Infections Treatment Sales by Country

5.1.1 Americas Acinetobacter Infections Treatment Sales by Country (2016-2021)

5.1.2 Americas Acinetobacter Infections Treatment Revenue by Country (2016-2021)

5.2 Americas Acinetobacter Infections Treatment Sales by Type

5.3 Americas Acinetobacter Infections Treatment Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Acinetobacter Infections Treatment Sales by Region

6.1.1 APAC Acinetobacter Infections Treatment Sales by Region (2016-2021)

6.1.2 APAC Acinetobacter Infections Treatment Revenue by Region (2016-2021)

6.2 APAC Acinetobacter Infections Treatment Sales by Type

6.3 APAC Acinetobacter Infections Treatment Sales by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

7 Europe

7.1 Europe Acinetobacter Infections Treatment by Country

7.1.1 Europe Acinetobacter Infections Treatment Sales by Country (2016-2021)

7.1.2 Europe Acinetobacter Infections Treatment Revenue by Country (2016-2021)

7.2 Europe Acinetobacter Infections Treatment Sales by Type

7.3 Europe Acinetobacter Infections Treatment Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Acinetobacter Infections Treatment by Country

8.1.1 Middle East & Africa Acinetobacter Infections Treatment Sales by Country (2016-2021)

8.1.2 Middle East & Africa Acinetobacter Infections Treatment Revenue by Country (2016-2021)

8.2 Middle East & Africa Acinetobacter Infections Treatment Sales by Type

8.3 Middle East & Africa Acinetobacter Infections Treatment Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Country

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Acinetobacter Infections Treatment Distributors

10.3 Acinetobacter Infections Treatment Customer

11 Global Acinetobacter Infections Treatment Market Forecast

11.1 Global Acinetobacter Infections Treatment Forecast by Region

11.1.1 Global Acinetobacter Infections Treatment Forecast by Regions (2021-2026)

11.2.2 Global Acinetobacter Infections Treatment Revenue Forecast by Regions (2021-2026)

11.2 Americas Forecast by Countries

11.3 APAC Forecast by Region

11.4 Europe Forecast by Countries

11.5 Middle East & Africa Forecast by Countries

11.6 Global Acinetobacter Infections Treatment Forecast by Type

11.7 Global Acinetobacter Infections Treatment Forecast by Application

12 Key Players Analysis

12.1 Entasis Therapeutics

12.1.1 Entasis Therapeutics Entasis Therapeutics Company Information

12.1.2 Entasis Therapeutics Acinetobacter Infections Treatment Product Offered

12.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.1.4 Entasis Therapeutics Main Business Overview

12.1.5 Entasis Therapeutics Latest Developments

12.2 Roche

12.2.1 Roche Company Information

12.2.2 Roche Acinetobacter Infections Treatment Product Offered

12.2.3 Roche Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.2.4 Roche Main Business Overview

12.2.5 Roche Latest Developments

12.3 Adenium Biotech

12.3.1 Adenium Biotech Company Information

12.3.2 Adenium Biotech Acinetobacter Infections Treatment Product Offered

12.3.3 Adenium Biotech Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.3.4 Adenium Biotech Main Business Overview

12.3.5 Adenium Biotech Latest Developments

12.4 Vaxdyn

12.4.1 Vaxdyn Company Information

12.4.2 Vaxdyn Acinetobacter Infections Treatment Product Offered

12.4.3 Vaxdyn Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.4.4 Vaxdyn Main Business Overview

12.4.5 Vaxdyn Latest Developments

12.5 Hsiri Therapeutics

12.5.1 Hsiri Therapeutics Company Information

12.5.2 Hsiri Therapeutics Acinetobacter Infections Treatment Product Offered

12.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.5.4 Hsiri Therapeutics Main Business Overview

12.5.5 Hsiri Therapeutics Latest Developments

12.6 Aridis Pharmaceuticals

12.6.1 Aridis Pharmaceuticals Company Information

12.6.2 Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Offered

12.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.6.4 Aridis Pharmaceuticals Main Business Overview

12.6.5 Aridis Pharmaceuticals Latest Developments

12.7 LegoChem Biosciences

12.7.1 LegoChem Biosciences Company Information

12.7.2 LegoChem Biosciences Acinetobacter Infections Treatment Product Offered

12.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.7.4 LegoChem Biosciences Main Business Overview

12.7.5 LegoChem Biosciences Latest Developments

12.8 Atterx Biotherapeutics

12.8.1 Atterx Biotherapeutics Company Information

12.8.2 Atterx Biotherapeutics Acinetobacter Infections Treatment Product Offered

12.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.8.4 Atterx Biotherapeutics Main Business Overview

12.8.5 Atterx Biotherapeutics Latest Developments

12.9 Achaogen

12.9.1 Achaogen Company Information

12.9.2 Achaogen Acinetobacter Infections Treatment Product Offered

12.9.3 Achaogen Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.9.4 Achaogen Main Business Overview

12.9.5 Achaogen Latest Developments

12.10 Peptilogics

12.10.1 Peptilogics Company Information

12.10.2 Peptilogics Acinetobacter Infections Treatment Product Offered

12.10.3 Peptilogics Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.10.4 Peptilogics Main Business Overview

12.10.5 Peptilogics Latest Developments

12.11 Sealife PHARMA

12.11.1 Sealife PHARMA Company Information

12.11.2 Sealife PHARMA Acinetobacter Infections Treatment Product Offered

12.11.3 Sealife PHARMA Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.11.4 Sealife PHARMA Main Business Overview

12.11.5 Sealife PHARMA Latest Developments

12.12 Shionogi

12.12.1 Shionogi Company Information

12.12.2 Shionogi Acinetobacter Infections Treatment Product Offered

12.12.3 Shionogi Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.12.4 Shionogi Main Business Overview

12.12.5 Shionogi Latest Developments

12.13 Techulon

12.13.1 Techulon Company Information

12.13.2 Techulon Acinetobacter Infections Treatment Product Offered

12.13.3 Techulon Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.13.4 Techulon Main Business Overview

12.13.5 Techulon Latest Developments

12.14 Tetraphase Pharmaceuticals

12.14.1 Tetraphase Pharmaceuticals Company Information

12.14.2 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Offered

12.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales, Revenue, Price and Gross Margin (2019-2021)

12.14.4 Tetraphase Pharmaceuticals Main Business Overview

12.14.5 Tetraphase Pharmaceuticals Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Acinetobacter Infections Treatment Consumption CAGR by Region (2020-2026) & ($ Millions)

Table 2. Major Players of Sulbactam

Table 3. Major Players of Carbapenems

Table 4. Major Players of Aminoglycosides

Table 5. Major Players of Polymyxins

Table 6. Major Players of Tetracyclines

Table 7. Major Players of Others

Table 8. Global Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)

Table 9. Global Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)

Table 10. Global Acinetobacter Infections Treatment Revenue by Type (2016-2021) & ($ million)

Table 11. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2016-2021)

Table 12. Global Acinetobacter Infections Treatment Sale Price by Type (2016-2021)

Table 13. Global Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)

Table 14. Global Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)

Table 15. Global Acinetobacter Infections Treatment Value by Application (2016-2021)

Table 16. Global Acinetobacter Infections Treatment Revenue Market Share by Application (2016-2021)

Table 17. Global Acinetobacter Infections Treatment Sale Price by Application (2016-2021)

Table 18. Global Acinetobacter Infections Treatment Sales by Company (2019-2021) & (Cases)

Table 19. Global Acinetobacter Infections Treatment Sales Market Share by Company (2019-2021)

Table 20. Global Acinetobacter Infections Treatment Revenue by Company (2019-2021) ($ Millions)

Table 21. Global Acinetobacter Infections Treatment Revenue Market Share by Company (2019-2021)

Table 22. Global Acinetobacter Infections Treatment Sale Price by Company (2019-2021)

Table 23. Key Manufacturers Acinetobacter Infections Treatment Producing Area Distribution and Sales Area

Table 24. Players Acinetobacter Infections Treatment Products Offered

Table 25. Acinetobacter Infections Treatment Concentration Ratio (CR3, CR5 and CR10) & (2019-2021)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Acinetobacter Infections Treatment Sales by Region (2016-2021) (Cases)

Table 29. Global Acinetobacter Infections Treatment Sales Market Share by Region (2016-2021)

Table 30. Global Acinetobacter Infections Treatment Revenue by Region (2016-2021) & ($ Millions)

Table 31. Global Acinetobacter Infections Treatment Revenue Market Share by Region (2016-2021)

Table 32. Americas Acinetobacter Infections Treatment Sales by Country (2016-2021) & (Cases)

Table 33. Americas Acinetobacter Infections Treatment Sales Market Share by Country (2016-2021)

Table 34. Americas Acinetobacter Infections Treatment Revenue by Country (2016-2021) & ($ Millions)

Table 35. Americas Acinetobacter Infections Treatment Revenue Market Share by Country (2016-2021)

Table 36. Americas Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)

Table 37. Americas Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)

Table 38. Americas Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)

Table 39. Americas Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)

Table 40. APAC Acinetobacter Infections Treatment Sales by Region (2016-2021) & (Cases)

Table 41. APAC Acinetobacter Infections Treatment Sales Market Share by Region (2016-2021)

Table 42. APAC Acinetobacter Infections Treatment Revenue by Region (2016-2021) & ($ Millions)

Table 43. APAC Acinetobacter Infections Treatment Revenue Market Share by Region (2016-2021)

Table 44. APAC Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)

Table 45. APAC Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)

Table 46. APAC Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)

Table 47. APAC Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)

Table 48. Europe Acinetobacter Infections Treatment Sales by Country (2016-2021) & (Cases)

Table 49. Europe Acinetobacter Infections Treatment Sales Market Share by Country (2016-2021)

Table 50. Europe Acinetobacter Infections Treatment Revenue by Country (2016-2021) & ($ Millions)

Table 51. Europe Acinetobacter Infections Treatment Revenue Market Share by Country (2016-2021)

Table 52. Europe Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)

Table 53. Europe Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)

Table 54. Europe Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)

Table 55. Europe Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)

Table 56. Middle East & Africa Acinetobacter Infections Treatment Sales by Country (2016-2021) & (Cases)

Table 57. Middle East & Africa Acinetobacter Infections Treatment Sales Market Share by Country (2016-2021)

Table 58. Middle East & Africa Acinetobacter Infections Treatment Revenue by Country (2016-2021) & ($ Millions)

Table 59. Middle East & Africa Acinetobacter Infections Treatment Revenue Market Share by Country (2016-2021)

Table 60. Middle East & Africa Acinetobacter Infections Treatment Sales by Type (2016-2021) & (Cases)

Table 61. Middle East & Africa Acinetobacter Infections Treatment Sales Market Share by Type (2016-2021)

Table 62. Middle East & Africa Acinetobacter Infections Treatment Sales by Application (2016-2021) & (Cases)

Table 63. Middle East & Africa Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)

Table 64. Global Acinetobacter Infections Treatment Sales Forecast by Type (2021-2026) & (Cases)

Table 65. Global Acinetobacter Infections Treatment Sales Market Share Forecast by Type (2021-2026)

Table 66. Global Acinetobacter Infections Treatment Revenue Forecast by Type (2021-2026) & ($ Millions)

Table 67. Global Acinetobacter Infections Treatment Revenue Market Share Forecast by Type (2021-2026)

Table 68. Global Acinetobacter Infections Treatment Sales Forecast by Application (2021-2026) & (Cases)

Table 69. Global Acinetobacter Infections Treatment Sales Market Share Forecast by Application (2021-2026)

Table 70. Global Acinetobacter Infections Treatment Revenue Forecast by Application (2021-2026) & ($ Millions)

Table 71. Global Acinetobacter Infections Treatment Revenue Market Share Forecast by Application (2021-2026)

Table 72. Entasis Therapeutics Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 73. Entasis Therapeutics Acinetobacter Infections Treatment Product Offered

Table 74. Entasis Therapeutics Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 75. Entasis Therapeutics Main Business

Table 76. Entasis Therapeutics Latest Developments

Table 77. Roche Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 78. Roche Acinetobacter Infections Treatment Product Offered

Table 79. Roche Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 80. Roche Main Business

Table 81. Roche Latest Developments

Table 82. Adenium Biotech Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 83. Adenium Biotech Acinetobacter Infections Treatment Product Offered

Table 84. Adenium Biotech Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 85. Adenium Biotech Main Business

Table 86. Adenium Biotech Latest Developments

Table 87. Vaxdyn Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 88. Vaxdyn Acinetobacter Infections Treatment Product Offered

Table 89. Vaxdyn Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 90. Vaxdyn Main Business

Table 91. Vaxdyn Latest Developments

Table 92. Hsiri Therapeutics Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 93. Hsiri Therapeutics Acinetobacter Infections Treatment Product Offered

Table 94. Hsiri Therapeutics Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 95. Hsiri Therapeutics Main Business

Table 96. Hsiri Therapeutics Latest Developments

Table 97. Aridis Pharmaceuticals Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 98. Aridis Pharmaceuticals Acinetobacter Infections Treatment Product Offered

Table 99. Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 100. Aridis Pharmaceuticals Main Business

Table 101. Aridis Pharmaceuticals Latest Developments

Table 102. LegoChem Biosciences Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 103. LegoChem Biosciences Acinetobacter Infections Treatment Product Offered

Table 104. LegoChem Biosciences Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 105. LegoChem Biosciences Main Business

Table 106. LegoChem Biosciences Latest Developments

Table 107. Atterx Biotherapeutics Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 108. Atterx Biotherapeutics Acinetobacter Infections Treatment Product Offered

Table 109. Atterx Biotherapeutics Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 110. Atterx Biotherapeutics Main Business

Table 111. Atterx Biotherapeutics Latest Developments

Table 112. Achaogen Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 113. Achaogen Acinetobacter Infections Treatment Product Offered

Table 114. Achaogen Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 115. Achaogen Main Business

Table 116. Achaogen Latest Developments

Table 117. Peptilogics Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 118. Peptilogics Acinetobacter Infections Treatment Product Offered

Table 119. Peptilogics Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 120. Peptilogics Main Business

Table 121. Peptilogics Latest Developments

Table 122. Sealife PHARMA Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 123. Sealife PHARMA Acinetobacter Infections Treatment Product Offered

Table 124. Sealife PHARMA Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 125. Sealife PHARMA Main Business

Table 126. Sealife PHARMA Latest Developments

Table 127. Shionogi Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 128. Shionogi Acinetobacter Infections Treatment Product Offered

Table 129. Shionogi Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 130. Shionogi Main Business

Table 131. Shionogi Latest Developments

Table 132. Techulon Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 133. Techulon Acinetobacter Infections Treatment Product Offered

Table 134. Techulon Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 135. Techulon Main Business

Table 136. Techulon Latest Developments

Table 137. Tetraphase Pharmaceuticals Basic Information, Acinetobacter Infections Treatment Manufacturing Base, Sales Area and Its Competitors

Table 138. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Product Offered

Table 139. Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales (Cases), Revenue ($ Million), Price (USD/Case) and Gross Margin (2019-2021E)

Table 140. Tetraphase Pharmaceuticals Main Business

Table 141. Tetraphase Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Acinetobacter Infections Treatment

Figure 2. Acinetobacter Infections Treatment Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Acinetobacter Infections Treatment Sales Growth Rate 2016-2026 (Cases)

Figure 7. Global Acinetobacter Infections Treatment Revenue Growth Rate 2016-2026 ($ Millions)

Figure 8. Acinetobacter Infections Treatment Sales by Region (2021 & 2026) & ($ millions)

Figure 9. Product Picture of Sulbactam

Figure 10. Product Picture of Carbapenems

Figure 11. Product Picture of Aminoglycosides

Figure 12. Product Picture of Polymyxins

Figure 13. Product Picture of Tetracyclines

Figure 14. Product Picture of Others

Figure 15. Global Acinetobacter Infections Treatment Sales Market Share by Type in 2020

Figure 16. Global Acinetobacter Infections Treatment Revenue Market Share by Type (2016-2021)

Figure 17. Acinetobacter Infections Treatment Consumed in ETX2514

Figure 18. Global Acinetobacter Infections Treatment Market: ETX2514 (2016-2021) & (Cases)

Figure 19. Acinetobacter Infections Treatment Consumed in Nacubactam RG6080

Figure 20. Global Acinetobacter Infections Treatment Market: Nacubactam RG6080 (2016-2021) & (Cases)

Figure 21. Acinetobacter Infections Treatment Consumed in Arenicin

Figure 22. Global Acinetobacter Infections Treatment Market: Arenicin (2016-2021) & (Cases)

Figure 23. Acinetobacter Infections Treatment Consumed in VXD-001

Figure 24. Global Acinetobacter Infections Treatment Market: VXD-001 (2016-2021) & (Cases)

Figure 25. Acinetobacter Infections Treatment Consumed in Small Molecule Antibiotic

Figure 26. Global Acinetobacter Infections Treatment Market: Small Molecule Antibiotic (2016-2021) & (Cases)

Figure 27. Acinetobacter Infections Treatment Consumed in AR-401 mAB

Figure 28. Global Acinetobacter Infections Treatment Market: AR-401 mAB (2016-2021) & (Cases)

Figure 29. Acinetobacter Infections Treatment Consumed in LCB01-0371 (PO)

Figure 30. Global Acinetobacter Infections Treatment Market: LCB01-0371 (PO) (2016-2021) & (Cases)

Figure 31. Acinetobacter Infections Treatment Consumed in GN-4474

Figure 32. Global Acinetobacter Infections Treatment Market: GN-4474 (2016-2021) & (Cases)

Figure 33. Acinetobacter Infections Treatment Consumed in Antibacterial Antibody

Figure 34. Global Acinetobacter Infections Treatment Market: Antibacterial Antibody (2016-2021) & (Cases)

Figure 35. Global Acinetobacter Infections Treatment Sales Market Share by Application (2016-2021)

Figure 36. Global Acinetobacter Infections Treatment Revenue Market Share by Application in 2020

Figure 37. Global Acinetobacter Infections Treatment Revenue Market by Company in 2020 ($ Million)

Figure 38. Global Acinetobacter Infections Treatment Revenue Market Share by Company in 2020

Figure 39. Global Acinetobacter Infections Treatment Sales Market Share by Regions (2016-2021)

Figure 40. Global Acinetobacter Infections Treatment Revenue Market Share by Region in 2020

Figure 41. Americas Acinetobacter Infections Treatment Sales 2016-2021 (Cases)

Figure 42. Americas Acinetobacter Infections Treatment Revenue 2016-2021 ($ Millions)

Figure 43. APAC Acinetobacter Infections Treatment Sales 2016-2021 (Cases)

Figure 44. APAC Acinetobacter Infections Treatment Revenue 2016-2021 ($ Millions)

Figure 45. Europe Acinetobacter Infections Treatment Sales 2016-2021 (Cases)

Figure 46. Europe Acinetobacter Infections Treatment Revenue 2016-2021 ($ Millions)

Figure 47. Middle East & Africa Acinetobacter Infections Treatment Sales 2016-2021 (Cases)

Figure 48. Middle East & Africa Acinetobacter Infections Treatment Revenue 2016-2021 ($ Millions)

Figure 49. Americas Acinetobacter Infections Treatment Sales Market Share by Country in 2020

Figure 50. Americas Acinetobacter Infections Treatment Revenue Market Share by Country in 2020

Figure 51. Americas Acinetobacter Infections Treatment Sales Market Share by Type in 2020

Figure 52. Americas Acinetobacter Infections Treatment Sales Market Share by Application in 2020

Figure 53. United States Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 54. Canada Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 55. Mexico Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 56. Brazil Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 57. APAC Acinetobacter Infections Treatment Sales Market Share by Region in 2020

Figure 58. APAC Acinetobacter Infections Treatment Revenue Market Share by Regions in 2020

Figure 59. APAC Acinetobacter Infections Treatment Sales Market Share by Type in 2020

Figure 60. APAC Acinetobacter Infections Treatment Sales Market Share by Application in 2020

Figure 61. China Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 62. Japan Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 63. Korea Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 64. Southeast Asia Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 65. India Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 66. Australia Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 67. Europe Acinetobacter Infections Treatment Sales Market Share by Country in 2020

Figure 68. Europe Acinetobacter Infections Treatment Revenue Market Share by Country in 2020

Figure 69. Europe Acinetobacter Infections Treatment Sales Market Share by Type in 2020

Figure 70. Europe Acinetobacter Infections Treatment Sales Market Share by Application in 2020

Figure 71. Germany Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 72. France Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 73. UK Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 74. Italy Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 75. Russia Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 76. Middle East & Africa Acinetobacter Infections Treatment Sales Market Share by Country in 2020

Figure 77. Middle East & Africa Acinetobacter Infections Treatment Revenue Market Share by Country in 2020

Figure 78. Middle East & Africa Acinetobacter Infections Treatment Sales Market Share by Type in 2020

Figure 79. Middle East & Africa Acinetobacter Infections Treatment Sales Market Share by Application in 2020

Figure 80. Egypt Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 81. South Africa Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 82. Israel Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 83. Turkey Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 84. GCC Country Acinetobacter Infections Treatment Revenue Growth 2016-2021 ($ Millions)

Figure 85. Channels of Distribution

Figure 86. Distributors Profiles